🎊@Rafabolism from the team Rosetta, and his lab, have been awarded a @ERC_Research Consolidator Grant. Rafa is one of 349 mid-career researchers to receive this year's Consolidator Grants. With funding from the EU’s Horizon Europe programme, these grants will support

📢 New Impact Report from SPECIFICANCER, the #CancerGrandChallenges team unravelling one of cancer biology’s hardest puzzles: tissue specificity. A huge thank you to the entire SPECIFICANCER team for their bold science, and to all our funders for enabling this endeavour. Thanks

What if we could spot cancer before it strikes — or while it’s still treatable? A new study published in @RSNA is bringing us a step closer to that goal. 🔗 Read more https://t.co/gMESDoOr0q Congratulations to Joseph Lo (@DukeMedSchool), Shelley Hwang (@DukeSurgery) and the

How can a gene mutation be present throughout the body yet cause cancer only in certain tissues? This is exactly the challenge our SPECIFICANCER team took on 7 years ago. Read the newly published impact report from the team that reshaped our understanding of tissue specificity

President Trump says it perfectly. A patchwork of 50 different state systems creates a maze of conflicting regulations, resulting in chaos. Follow me to join the conversation on leading the AI revolution.

Register today to join the conversation that reframes cancer from being about the tumour to being about the host-tumour dialogue. Gain insights that might change how we think about and treat cancer. Cancer does not develop in isolation. Cancer and the host will challenge us to

Explore how cancer research can prepare to unlock the full potential of data-driven innovation at the @CR_UK upcoming Data-driven cancer research conference in Edinburgh from 24-26 February 2026. @MeliD32, team lead of the SAMBAI team, will close the conference by chairing a

🧬 Sponsor the #CancerGrandChallenges Spatial biology conference and join the community redefining how we see cancer. Sponsorship offers access to the scientists and innovators driving innovation, brand visibility, and opportunities to engage with leaders in AI, imaging,

Greatness begins with a question.

What if a cancer-causing mutation were less like a ticking time bomb and more like an actor waiting for the right opportunity? Team SPECIFICANCER’s brand new paper gives us an insight. The new paper from SPECIFICANCER, published in @Nature, reveals that it’s not just the

🎉 Congratulations to @kinglhung from team eDyNAmiC for receiving the prestigious Science & SciLifeLab Prize for Young Scientists and for having his essay, “Oncogenes out of context: Cancer genes break free from the regulatory constraints of chromosomes”, published in

🎉 Celebrating excellence in global cancer research. We’re proud to share that 25 individuals from our international #CancerGrandChallenges community have been named among the Clarivate Highly Cited Researchers 2025. To every awardee across our Cancer Grand Challenges community

And that’s a wrap for the #CancerGrandChallenges Future Leaders' Conference 2025! This conference wasn’t just about sharing what’s been done—it was about igniting what comes next. The inspiration, the optimism, and the connections we witnessed will drive real progress in

Congratulations to team PROSPECT for being featured in The @nytimes for their study identifying a possible association between ultra-processed food consumption and risk of bowel polyps in younger women. Thank you also to our co-funders and partners for making this work possible,

🔬 New research from #CancerGrandChallenges team PROSPECT explores possible links between diet and risk of bowel polyps in younger women. Thank you to our co-funders and partners for making this work possible, @CR_UK, @theNCI, the Bowelbabe Fund and @Institut_cancer. PROSPECT is

Our favorite piping hot hosting hack (literally) ♨️

“Take the most exciting options, take risks and be bold” We heard powerful motivational words today from Karen Vousden, Principal Group Leader at @TheCrick and #CancerGrandChallenges Scientific Committee member, at day one of our Cancer Grand Challenges Future Leaders’

A major leap in antibody design! Members of CGC #NexTGen (co-funded by @TheMarkFdn), Nikolaos Sgourakis & John Maris, contributed to a new Nature paper from David Baker’s lab showing AI-designed antibodies with atomic-level precision. A potential game-changer for how we discover

We’re shifting how we think about cancer. Often it's thought of as cells in isolation. But cancer doesn’t act alone — it hijacks the host. This different focus matters because: •Tumours don’t just grow; they co-opt immune, metabolic and neural networks in the body. •Your age,

What barriers do you think are holding back progress in cancer research? Yesterday, @Iain_CRUK, Executive Director of Research & Innovation at @CR_UK and CEO of @CR_Horizons, joined the panel “Conquering Cancer: Innovations Closing Gaps and Improving Outcomes” at the

Democrats have a fraud problem! A big one. And the past few weeks have shown just how much it costs Americans. FGA’s @ingramlaw sounds off in his latest for @NYPostOpinion. ⤵️

💡 New research from the #CancerGrandChallenges NexTGen team offers a way to make CAR T-cell therapy more effective — even against cancers that try to hide. This study is part of the NexTGen project, supported by @CR_UK, the @theNCI, and @TheMarkFdn through the Cancer Grand

🎉 Congratulations to Sir Mike Stratton (Team Lead) and Paul Brennan (Co-Investigator) of team Mutographs who have been awarded a @ERC_Research Synergy grant of €10.4m to continue researching the association between early-onset colorectal cancer and the colibactin mutational